MedPath

Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients

Not Applicable
Conditions
Alzheimer Disease
Depression
Registration Number
NCT02840045
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The purpose of this study is to use a new method to differentiate mnesic abilities of early alzheimer patients and patients with a depressive disorder.

This method is based on the recording of cerebral activity while patients listen to familiar, unfamiliar and newly-learned music.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Being right-handed
  • recorded consent
  • For Alzheimer patients: Mini Mental Status Examination (MMSE) score >= 18
  • For patients with a depressive disorder : Major Depressive Disorder according to Diagnostic and Statistical Manual of Mental Disorders (DSM IV) and Montgomery-Asberg depression rating scale (MADRS) score >= 25
  • For healthy controls : no cognitive deficit, MADRS score < 25, no depressive disorder according to DSM IV
Exclusion Criteria
  • Auditory deficit
  • contraindication to a high-density electroencephalography exam
  • refusal to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Amplitude of event-related potentialsday 1 for familiar and unfamiliar songs and day 14 for newly learned songs

Measurements of the amplitude of event-related potentials with electroencephalography at day one for familiar and unfamiliar songs and after 2 weeks for newly learned songs

Secondary Outcome Measures
NameTimeMethod
Spectral powerday 1 for familiar and unfamiliar songs and day 14 for newly learned songs

Measurements of the spectral power with electroencephalography at day one for familiar and unfamiliar songs and after 2 weeks for newly learned songs

Trial Locations

Locations (1)

CHRU Besançon

🇫🇷

Besancon, Franche-Comte, France

CHRU Besançon
🇫🇷Besancon, Franche-Comte, France
Damien Gabriel, PhD
Contact
0033381219148
dgabriel@chu-besancon.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.